DuPont Photovoltaic Solutions Attacks Global Marketplace

DuPont Photovoltaic Solutions (DPVS) recently exhibited a broad and growing portfolio of films, resins for encapsulants, encapsulant films, conductive pastes and more, at the 22nd European Photovoltaic Solar Energy Conference and Exhibition in Milan, Italy.

More than 12,000 participants from 75 countries attended the event, where DPVS highlighted its latest technologies for both crystalline and thin film solar module systems, designed to increase the lifetime of solar modules, and improve productivity of photovoltaic module makers. DuPont also emphasized significant capacity expansion programs, in line with expected growth in the industry.

DuPont Photovoltaic Solutions exhibited a broad and growing range of materials at the European Solar Energy Conference.

“High performing materials are the essence of more efficient and longer lasting photovoltaic modules that are easier to install. These qualities are key to meeting customer needs, and DuPont has been putting our science to work to help our photovoltaic customers succeed for more than 20 years,” said Stacy Dedinas, global business manager, DuPont Photovoltaic Solutions.

DuPont and the solar industry estimate that the global photovoltaic market is growing more than 30 percent per year. To meet the needs of the fast-growing market, DuPont last year announced that it has invested USD 50 million to expand production of DuPont™ Tedlar® polyvinyl fluoride film (PVF) at its Fayetteville, N.C., facility, which is on track to begin resin production late this year. Finished films are expected to be available in the first quarter of 2008. Coupled with additional expansions for other DuPont photovoltaic materials, DuPont's total investment is about USD 100 million

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.